No title provided

Grant number: 335524

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2021
  • Known Financial Commitments (USD)

    $1,164,926.68
  • Funder

    Academy of Finland
  • Principal Investigator

    Anu Liikanen
  • Research Location

    Finland
  • Lead Research Institution

    University of Eastern Finland
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The University of Eastern Finland will join the fight against the COVID-19 pandemic with multidisciplinary research approaches and collaboration. The sub-projects will focus on 1) health effects and care in SARS-CoV-2 infection, 2) lifespan of SARS-CoV-2, its spread, stability and detection, and 3) societal impacts of the COVID-19 pandemic. Research is carried out both in national and international collaboration together with world-leading experts. Research will provide solutions on how to prevent SARS-CoV-2 outbreaks and how to diminish both health and societal effects of the COVID-19 pandemic on a national and global scale.

Publicationslinked via Europe PMC

Tree Species-Dependent Inactivation of Coronaviruses and Enteroviruses on Solid Wood Surfaces.

Exposure to urban particulate matter alters responses of olfactory mucosal cells to SARS-CoV-2 infection.

Consistent service use before the COVID-19 pandemic predicted the continuity of face-to-face appointments during the lockdown among type 2 diabetes patients.

Human-derived air-liquid interface cultures decipher Alzheimer's disease-SARS-CoV-2 crosstalk in the olfactory mucosa.

Mechanistic Understanding of the Olfactory Neuroepithelium Involvement Leading to Short-Term Anosmia in COVID-19 Using the Adverse Outcome Pathway Framework.

The adverse effect of the COVID-19 pandemic on health service usage among patients with type 2 diabetes in North Karelia, Finland.

The Adverse Outcome Pathway Framework Applied to Neurological Symptoms of COVID-19.

Dementia Risk Scores and Their Role in the Implementation of Risk Reduction Guidelines.

Everyday Life Meaningfulness for the Community-Dwelling Oldest Old During the COVID-19 Pandemic.